Jubilant Generics Limited

We are a global vertically integrated pharmaceutical company engaged in research and development, manufacture, sale and distribution of prescription and OTC pharmaceutical products, with global presence in more than 50 countries, including United States, Europe, Canada, Japan, Australia and Rest of the World. We offer a wide range of proprietary finished dosage formulation catering to different therapeutic segments, including CVS, CNS, gastro-intestinal, etc.

Ind-Swift Laboratories Ltd.

Established in 1995, Ind-Swift has fast evolved towards a business model that is focused on deep-rooted domestic presence and has leveraged on high-value mature regulated markets with considerable growth in emerging markets. With world class manufacturing sites, independent State-of-the-Art R&D Centre and Regulatory approvals, the Group has embarked upon a journey to establish itself as a reliable partner in the Global Pharmaceutical Industry. In house capabilities for Development of APIs, Finished Dosage forms, Non-Infringing Process & World Class facilities for Contract Manufacturing are our inherent strengths. Ind-Swift Laboratories Ltd. is ethically driven organization that believes in bringing positive change in the world. We have been able to persist in volatile industrial conditions by our determination to deliver products that consistently confirm global quality standards. ISLL has transformed itself into an integrated, state of the art pharmaceutical manufacturer and we are on a Journey to attain unmatched heights in Industry. We are a firm incorporated with an aim to cater to the global needs of a “healthy world” through our quality products and services provided to existing and potential customers. With hands on diverse Industrial Experience, our team serves the best pharmaceutical products, ingredients and solutions custom-tailored to every client’s specific business need.

Sai Life Sciences Ltd

Sai Life Sciences is built on the bedrock of partnership. We work with innovator pharma and biotech companies to accelerate the discovery, development and manufacture of complex small molecules for a healthier tomorrow. Our Vision is to support our global innovator partners bring 25 new medicines to life by 2025. And we are well on that journey.

Morepen Laboratories Limited India

Morepen is a market leader in glucometers, having installed over 12 million units to date and sold nearly 1.6 million blood glucose strips, driven by an aggressive market expansion strategy into tier-2 and tier-3 cities. As a leading manufacturer of BP monitors, the company has shown impressive growth in the Point of Care (POC) diagnostics segment. In the API business, Morepen holds a leadership position in the export of six key API products: Loratadine, Montelukast, Desloratadine, Atorvastatin, and Fexofenadine, catering to numerous international markets and exporting to over 80 countries. Approximately 68% of Morepen's API products are exported, highlighting its extensive global reach. The company has demonstrated consistent growth in both its top and bottom lines through strategic investments and market expansions. Morepen maintains a debt-free status with robust financials and a negligible interest burden, underscoring its financial stability. Founded in 1984, Morepen Laboratories Limited (www.morepen.com) has established itself as a prominent leader in the pharmaceutical industry, renowned for its high-quality products and innovative solutions. The company offers a diverse range of products, including active pharmaceutical ingredients, diagnostics, and over-the-counter items. Morepen is dedicated to enhancing global health through its advanced research and development efforts.

Navin Fluorine International Ltd.

Navin Fluorine International Ltd (NFIL) is a reliable global leader offering organo-fluorine chemistry expertise for nearly 50 years with operations in UK &India, that spans customers’ with seamless, fully integrated and turn-key operations delivering quality material on time, at all scales (cGMP and non-cGMP) making us your trusted partner from discovery to commercial production. NFIL has four main strategic business units: • Refrigeration Gases • Inorganic Fluorides • Speciality Fluorides • Contract Research And Manufacturing Services (CRAMS) Our contract research services aims at developing process chemistry, novel analogues and derivatives around the customers’ target molecules to support research and discovery activities. Our subsidiary company in the UK, Manchester Organics Limited participates in this early discovery phase with the innovator customers. Our cGMP pilot plant facility at Dewas, enables us to supply specialized and niche fluorinated molecules from milligram to multi-kilogram level quantities. The pilot facility supports bio-pharmaceuticals, crop protection and other specialty chemical sectors right through product development life cycles. With high focus on fluorine chemistry and to support development of new products, NFIL is making further investments in strengthening its manufacturing capabilities by building a world class cGMP multi-purpose plant to supply and service multi ton requirements of customers. Our rapidly expanding catalog currently contains over 40,000 compounds, many of which are manufactured in our own laboratories. NFIL have emerged as a preferred source and a partner of choice for a variety of fluorochemicals globally. A high standard of quality, health, safety and environment has always remained a priority at NFIL. We have quality system accreditation with ISO 9001, environment management system accreditation with ISO 14001 and safety management accreditation with an OHSAS-18001.